ZYME

22.88

1.51% -0.35

Dopo l'orario di chiusura: 22.26 -0.62 -2.71%

Zymeworks Inc. (ZYME)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Forum Previsione

Precedente Chiudi:

$23.23

Aprire:

$23.42

Volume 24 ore:

787.22K

Relative Volume:

1.06

Capitalizzazione di mercato:

$1.70B

Reddito:

$105.97M

Utile/perdita netta:

$-81.13M

Rapporto P/E:

-21.20

EPS:

-1.0791

Flusso di cassa netto:

$-35.43M

1 W Prestazione:

-4.98%

1M Prestazione:

+1.24%

6M Prestazione:

+45.36%

1 anno Prestazione:

+82.31%

Intervallo 1D:

$22.43

$23.89

Intervallo di 1 settimana:

$22.43

$28.00

Portata 52W:

$9.03

$28.49

Zymeworks Inc. Stock (ZYME) Company Profile

Nome

Zymeworks Inc.

Settore

Healthcare (1116)

Industria

Biotechnology (621)

Telefono

604-678-1388

Indirizzo

1385 West 8th Avenue, Suite 540, Vancouver, BC

Dipendente

170

Cinguettio

@ZymeworksInc

Prossima data di guadagno

2026-03-02

Ultimi documenti SEC

ZYME's Discussions on Twitter

Compare ZYME vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ZYME Zymeworks Inc.	22.88	1.70B	105.97M	-81.13M	-35.43M	-1.0791
VRTX Vertex Pharmaceuticals Inc	469.34	119.23B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	745.77	78.84B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	700.45	43.35B	4.16B	1.29B	734.26M	19.59
ALNY Alnylam Pharmaceuticals Inc	313.41	41.57B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	284.05	31.51B	5.36B	287.73M	924.18M	2.5229

Zymeworks Inc. Stock (ZYME) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-12	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2025-12-03	Iniziato	Citizens JMP	Mkt Outperform
2025-10-24	Ripresa	Wells Fargo	Equal Weight
2025-10-14	Aggiornamento	H.C. Wainwright	Neutral → Buy
2025-10-10	Iniziato	B. Riley Securities	Buy
2025-05-20	Iniziato	TD Cowen	Buy
2024-12-16	Aggiornamento	JP Morgan	Neutral → Overweight
2024-11-07	Aggiornamento	Leerink Partners	Market Perform → Outperform
2024-11-01	Downgrade	Wells Fargo	Overweight → Equal Weight
2023-03-21	Ripresa	Wells Fargo	Overweight
2023-01-04	Reiterato	H.C. Wainwright	Neutral
2022-12-20	Aggiornamento	Jefferies	Hold → Buy
2022-11-01	Downgrade	H.C. Wainwright	Buy → Neutral
2022-10-21	Downgrade	SVB Leerink	Outperform → Mkt Perform
2022-10-04	Ripresa	Wells Fargo	Overweight
2022-05-05	Aggiornamento	Guggenheim	Neutral → Buy
2022-03-15	Iniziato	Evercore ISI	Outperform
2021-12-10	Aggiornamento	SVB Leerink	Mkt Perform → Outperform
2021-11-17	Ripresa	Guggenheim	Neutral
2021-10-07	Iniziato	Jefferies	Hold
2021-03-31	Iniziato	Credit Suisse	Outperform
2021-02-25	Downgrade	SVB Leerink	Outperform → Mkt Perform
2021-02-08	Ripresa	H.C. Wainwright	Buy
2021-01-25	Downgrade	Citigroup	Buy → Neutral
2020-09-29	Ripresa	JP Morgan	Neutral
2020-08-06	Iniziato	SVB Leerink	Outperform
2020-01-10	Iniziato	Wolfe Research	Outperform
2019-12-09	Iniziato	JP Morgan	Neutral
2019-11-25	Iniziato	H.C. Wainwright	Buy
2019-11-20	Iniziato	Guggenheim	Buy
2019-09-30	Aggiornamento	Raymond James	Outperform → Strong Buy
2019-08-30	Iniziato	Stifel	Buy
2019-07-18	Iniziato	Deutsche Bank	Buy
2018-05-11	Aggiornamento	Barclays	Underweight → Equal Weight
2018-03-19	Iniziato	Raymond James	Outperform

Mostra tutto

Zymeworks Inc. Borsa (ZYME) Ultime notizie

11:22 AM

Wall Street Analysts See a 76.74% Upside in Zymeworks (ZYME): Can the Stock Really Move This High? - MSN

11:22 AM

07:11 AM

Prosight Management LP Cuts Stake in Zymeworks Inc. $ZYME - MarketBeat

07:11 AM

Mar 12, 2026

Value Recap: Does Zymeworks Inc have strong EBITDA marginsTrade Analysis Report & Accurate Buy Signal Notifications - baoquankhu1.vn

Mar 12, 2026

Mar 10, 2026

Zymeworks (NASDAQ:ZYME) Trading Up 9.7%What's Next? - MarketBeat

Mar 10, 2026

Assessing Zymeworks (ZYME) Valuation After Q4 Updates And Improved Clinical And Funding Outlook - Sahm

Mar 10, 2026

Mar 09, 2026

Zymeworks (ZYME) Price Target Raised to $48 by Evercore ISI Grou - GuruFocus

Mar 09, 2026

Mar 08, 2026

Will Zymeworks' (ZYME) Wider Losses and ESOP Shelf Offering Recast Its Long-Term Equity Story? - Sahm

Mar 08, 2026

Mar 06, 2026

Zymeworks FY25 Review: From Milestone Volatility To 2026 Upside (NASDAQ:ZYME) - Seeking Alpha

Mar 04, 2026

Zymeworks Inc. (NASDAQ:ZYME) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Mar 04, 2026

Mar 03, 2026

Zymeworks (NASDAQ:ZYME) Trading 2.8% Higher on Analyst Upgrade - MarketBeat

Mar 03, 2026

Forecasting The Future: 4 Analyst Projections For Zymeworks - Benzinga

Mar 03, 2026

Zymeworks (ZYME) Target Price Raised by Leerink Partners to $58 - GuruFocus

Mar 03, 2026

Stifel raises Zymeworks stock price target on royalty deal value By Investing.com - Investing.com Canada

Mar 03, 2026

Stifel raises Zymeworks stock price target on royalty deal value - Investing.com

Mar 03, 2026

Zymeworks Inc. (NASDAQ:ZYME) Q4 2025 Earnings Call Transcript - Insider Monkey

Mar 03, 2026

Citizens reiterates Zymeworks stock rating on strong cash position - Investing.com Nigeria

Mar 03, 2026

Citizens reiterates Zymeworks stock rating on strong cash position By Investing.com - Investing.com Australia

Mar 03, 2026